Evaluating Treatment Response in Laryngo-Pharyngeal Reflux

NCT01328392 · clinicaltrials.gov ↗

NA

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped The sponsor did not fund the study.

Conditions

Laryngo-pharyngeal Reflux

Interventions

DRUG: Dexlansoprazole

Sponsor

University of Washington

Collaborators

[object Object]